Investment
Features
FeesSafety
Academy
More
Pluang+

Nuveen S&P 500 Dynamic Overwrite Fund trades at a discount, offering income investors a good entry point.

Market News
22 Sep 2026
Seeking Alpha
View Source
Bullish
Nuveen S&P 500 Dynamic Overwrite Fund trades at a discount, offering income investors a good entry point.

The Nuveen S&P 500 Dynamic Overwrite Fund (SPXX) is currently trading at a significant discount, making it an attractive option for income-focused investors. The fund uses a dynamic call overwrite strategy on an S&P 500-like portfolio to limit upside gains typical in such funds. Despite this opportunity, investors should be cautious due to high equity valuations in the market, and a dollar-cost averaging approach might be safer. This fund is popular among income investors seeking monthly payouts and stable yields above 8%.

The Nuveen S&P 500 Dynamic Overwrite Fund (SPXX) is noted here with market data from Pluang's US stocks. For readers following US equities, here is Pluang's market snapshot as of Sep 22, 2026 19:41 WIB: out of 150 priced stocks, 105 rose and 40 fell. Among notable movers, SOFI gained 6.13% to USD 18.01, SHOP rose 5.50% to USD 145.50, and GRAB increased 4.81% to USD 3.05.

More News

THOR Industries misses Q4 EPS estimates but beats revenue expectations amid RV market challenges

THOR Industries misses Q4 EPS estimates but beats revenue expectations amid RV market challenges

THOR Industries reported Q4 earnings with an EPS of $0.78, missing analyst estimates and showing a 66.9% drop from last year. Despite this, the company beat revenue expectations with $2.31 billion, though revenue declined 8.4% year-over-year due to w...

Company Fundamentals
Bearish
1 hour ago
Cracker Barrel earnings expected to drop sharply in Q3 2026, with EPS forecast at $0.17 and revenue down.

Cracker Barrel earnings expected to drop sharply in Q3 2026, with EPS forecast at $0.17 and revenue down.

Cracker Barrel Old Country Store is set to report its Q3 2026 earnings on September 23, with analysts predicting a significant decline. Earnings per share are expected to fall to $0.17 from $0.74 last year, and revenue is forecasted around $834.57 mi...

Company Fundamentals
Bearish
1 hour ago
Abivax gains FDA nod for Obefazimod, backed by strong cash and positive analyst outlook.

Abivax gains FDA nod for Obefazimod, backed by strong cash and positive analyst outlook.

Abivax received positive pre-NDA feedback from the U.S. FDA for its drug Obefazimod, marking a key step in its development. Despite a recent price target cut by Wedbush to $118, analysts maintain a "Moderate Buy" consensus with an average target of $...

Market News
Bullish
2 hours ago
Netflix stock downgraded by HSBC and Wells Fargo over falling viewer engagement.

Netflix stock downgraded by HSBC and Wells Fargo over falling viewer engagement.

HSBC and Wells Fargo have downgraded Netflix stock due to declining subscriber engagement and an 8% drop in viewership time. Despite a recent 2.19% stock gain, Netflix shares have fallen over 40% in the past year amid strong competition and weaker or...

Market News
Bearish
2 hours ago
FormFactor director sells 2,100 shares, signaling insider stock movement

FormFactor director sells 2,100 shares, signaling insider stock movement

A director at FormFactor sold 2,100 shares, indicating a notable insider transaction. Such sales can reflect personal financial decisions or strategic portfolio adjustments by company insiders. Investors often watch these moves for potential signals ...

Market News
Bearish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App